Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray

Home




MEDIR is a specialty pharmaceutical company, seeking to address the areas of high unmet medical needs in: 1. inducing mild sedation in a safe, convenient and needlefree way; and 2. offering a treatment for acute epileptic seizure control outside a hospital setting, that is fast, efficacious and easy adminstered.
The company has developed nasal sprays containing midazolam, a compound that currently needs to be administered by intravenous injection for predicitive results. MEDIR is in the process of generating the CMC-, non-clinical- and clinical dataset, necessary to obtain marketing authorisation for the nasal spray product.

Commercialization rights will be out-licensed to partners. Nasal midazolam is not registered anywhere in the world yet.
© 2011 Medir. All rights reserved.